MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD)

S. Madiha, S. Haider (Karachi, Pakistan)

Meeting: 2018 International Congress

Abstract Number: 1234

Keywords: Cognitive dysfunction, Oxidative stress, Rotenone

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Cognition

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: In this study, we aimed to investigate the neuroprotective effect of curcumin against rotenone-induced memory impairments in rat PD model.

Background: In PD, oxidative stress has been stated to induce cognitive dysfunction. Rotenone-induced animal model mimicked characteristics features of PD including oxidative stress. So, therapeutic interventions that can prevent free radicals mediated neurodegeneration by inhibiting free radical production may be useful in preventing disease progression. Curcumin a natural occurring polyphenolic antioxidant and exhibits neuroprotection against different neurodegenerative diseases.

Methods: Adult male rats were administered subcutaneously with rotenone (1.5 mg/kg/day) for 8 days in order to develop PD-like symptoms. After the development of PD-like symptoms curcumin (100 mg/kg/day, p.o) was administered in respective group for two weeks. Cognitive functions were monitored by the morris water maze test (MWM) and novel object recognition task (NOR). Biochemical and neurochemical estimations were done in brain.

Results: Results showed that rotenone administration significantly (p<0.01) induced memory impairment in behavioral parameters and as well as significantly (p<0.01) produced oxidative stress as evident by increased lipid peroxidation (LPO) and decreased reduced glutathione (GSH) levels as compared to controls. Moreover, rotenone significantly (p<0.01) decreased dopamine (DA) and 5-hydroxytryptamine (5-HT) levels. Curcumin treatment significantly improved memory acquisition by significantly (p<0.01) decreased LPO and increased GSH levels. Curcumin significantly increased DA and 5-HT levels as compared to rotenone alone group (p<0.01).

Conclusions: Hence, our result indicated that curcumin exhibits antioxidant activity against rotenone-induced cognitive impairment. The findings of the present study strongly suggest that cognitive improving effect of curcumin might be attributed to its antioxidant properties.

References: 1) Sriraksa N, Wattanathorn J, Muchimapura S, Tiamkao S, Brown K, Chaisiwamongkol K (2012) Cognitive-enhancing effect of quercetin in a rat model of Parkinson’s disease induced by 6-hydroxydopamine. Evid Based Complement Alternat Med 2012:823206. 2) Madiha S, Tabassum S, Batool Z, Liaquat L, Sadir S, Shahzad S, Perveen T, Haider S (2017) Assessment of gait dynamics in rotenone-induced rat model of Parkinson’s disease by footprint method. Pak J Pharm Sci 30:943-948.

To cite this abstract in AMA style:

S. Madiha, S. Haider. Curcumin improves cognitive function in rotenone-induced rat model of Parkinson’s disease (PD) [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/curcumin-improves-cognitive-function-in-rotenone-induced-rat-model-of-parkinsons-disease-pd/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/curcumin-improves-cognitive-function-in-rotenone-induced-rat-model-of-parkinsons-disease-pd/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley